Serotonin and dopamine transporter (SERT, DAT) availabilities as assessed by b-CIT [beta carbomethoxy-3 beta-(4-iodophenyl) tropane] and SPECT [single photon emission computed tomography], and neurophysiological measures of central serotonergic activity in patients with depression under treatment with escitalopram.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2010
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics
- 01 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2008 New trial record.